Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections

References

• Marcelin G, Sandbulte MR, Webby RJ. Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. Rev Med Virol. 2012;22:267–279.
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–5096.
   PubMed Web of Science ®Google Scholar
• Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;76:105–115.
   PubMed Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(391):1285–1300.
   PubMedGoogle Scholar
• Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine. 2008;26(Suppl 4):D17–D22.
   PubMed Web of Science ®Google Scholar
• Gerdil C. The annual production cycle for influenza vaccine. Vaccine. 2003;21:1776–1779.
   PubMed Web of Science ®Google Scholar
• Cox RJ. Correlates of protection to influenza virus, where do we go from here? Hum Vaccin Immunother. 2013;9:405–408.
   PubMed Web of Science ®Google Scholar
• Petrie JG, Ohmit SE, Johnson E, et al. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis. 2011;203:1309–1315.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Petrie JG, Cross RT, et al. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011;204:1879–1885.
   PubMed Web of Science ®Google Scholar
• Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30:1081–1085.
   PubMed Web of Science ®Google Scholar
• CDC. Seasonal influenza vaccine effectiveness, 2005–2018. [Cited 2018 Mar 22]. Available from: http://wwwcdcgov/flu/professionals/vaccination/effectiveness
   Google Scholar
• Memoli MJ, Shaw PA, Han A, et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. MBio. 2016;7:e00417-16.
   PubMed Web of Science ®Google Scholar
• Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945–1952.
   PubMed Web of Science ®Google Scholar
• Pascua PNQ, Song M-S, Lee JH, et al. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One. 2009;4:e8431.
   PubMed Web of Science ®Google Scholar
• Ellebedy AH, Ducatez MF, Duan S, et al. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. Vaccine. 2011;29:3335–3339.
   PubMed Web of Science ®Google Scholar
• Laurie KL, Carolan LA, Middleton D, et al. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis. 2010;202:1011–1020.
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Ng S, Ma ESK, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis. 2010;51:1370–1379.
   PubMed Web of Science ®Google Scholar
• Chen YQ, Wohlbold TJ, Zheng N-Y, et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell. 2018;173:417–429.e10.
   PubMed Web of Science ®Google Scholar
• Sandbulte MR, Jimenez GS, Boon AC, et al. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med. 2007;4:e59.
   PubMed Web of Science ®Google Scholar
• Marcelin G, Bland H, Negovetich N, et al. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. J Infect Dis. 2010;202:1634–1638.
   PubMed Web of Science ®Google Scholar
• Cate TR, Rayford Y, Niño D, et al. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine. 2010;28:2076–2079.
   PubMed Web of Science ®Google Scholar
• Park JK, Han A, Czajkowski L, et al. Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A/H1N1pdm virus. MBio. 2018;9:pii:e02284-17.
   Web of Science ®Google Scholar
• Monto AS, Petrie JG, Cross RT, et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J Infect Dis. 2015;212:1191–1199.
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med. 2010;362:2175–2184.
   PubMed Web of Science ®Google Scholar
• Ip DKM, Lau LLH, Chan KH, et al. The dynamic relationship between clinical Symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections. Clin Infect Dis. 2016;62:431–437.
   PubMed Web of Science ®Google Scholar
• Couch RB, Atmar RL, Franco LM, et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis. 2013;207:974–981.
   PubMed Web of Science ®Google Scholar
• Wu JT, Ma E, Lee C, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis. 2010;51:1184–1191.
   PubMed Web of Science ®Google Scholar
• Rajendran M, Nachbagauer R, Ermler ME, et al. Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic sin. MBio. 2017;8(2):pii:e02281-16.
   Web of Science ®Google Scholar
• Sandbulte MR, Westgeest KB, Gao J, et al. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci USA. 2011;108:20748–20753.
   PubMed Web of Science ®Google Scholar
• Huang QS, Bandaranayake D, Wood T, et al. Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study. J Infect Dis. 2018. DOI:10.1093/infdis/jiy443.
   Google Scholar
• Cowling BJ, Sullivan SG. The value of neuraminidase inhibition antibody titers in influenza seroepidemiology. J Infect Dis. 2018. DOI:10.1093/infdis/jiy446.
   Web of Science ®Google Scholar
• Couch RB, Kasel JA, Gerin JL, et al. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis. 1974;129:411–420.
   PubMed Web of Science ®Google Scholar
• Monto AS, Kendal AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet. 1973;1(7804):623–625.
   PubMed Web of Science ®Google Scholar
• Ogra PL, Chow T, Beutner KR, et al. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis. 1977;135:499–506.
   PubMed Web of Science ®Google Scholar
• Hoffmann E, Neumann G, Kawaoka Y, et al. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA. 2000;97:6108–6113.
   PubMed Web of Science ®Google Scholar
• Lambre CR, Terzidis H, Greffard A, et al. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods. 1990;135:49–57.
   PubMed Web of Science ®Google Scholar
• Eichelberger MC, Couzens L, Gao Y, et al. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity. Vaccine. 2016;34:458–465.
   PubMed Web of Science ®Google Scholar
• Gao J, Couzens L, Eichelberger MC. Measuring influenza neuraminidase inhibition antibody titers by enzyme-linked lectin assay. J Vis Exp. 2016;115:e54573.
   Google Scholar